Drug
HSK44459 clinical trials
Also written HSK44459.
- studies test it
- 10
- open now
- 6
- in phase 3
- 2
- first study started
- 2024
Keep track of what changes. Save the HSK44459 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
10 studies that test it; most in 2025 (6)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 7
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Haisco Pharmaceutical Group Co., Ltd. (9) · Xizang Haisco Pharmaceutical Co., Ltd (1)
Studies
Open first, then newest update. How each study uses HSK44459 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary FibrosisNot yet recruitingPhase 3Haisco Pharmaceutical Group Co., Ltd.NCT07519070Written as HSK44459
- Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary FibrosisNot yet recruitingPhase 3Haisco Pharmaceutical Group Co., Ltd.NCT07503587Written as HSK44459
- A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque PsoriasisNot yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07150988Written as HSK44459 dose level 1
- A Long-term Study of HSK44459 Tablets in Participants With Bechet's DiseaseNot yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07070739Written as HSK44459 tablets
- Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)Not yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07019090Written as HSK44459
- Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's DiseaseNot yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT06902428Written as HSK44459
- Trial of HSK44459 Cream for the Management Plaque PsoriasisActive, not recruitingPhase 1/2Haisco Pharmaceutical Group Co., Ltd.NCT07623486Written as HSK44459 Cream
- Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary FibrosisCompletedPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT06764862Written as HSK44459 dose 1
- A Study for HSK44459 in Participants With Atopic DermatitisActive, not recruitingPhase 2Xizang Haisco Pharmaceutical Co., LtdNCT06996912Written as HSK44459
- A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy SubjectsCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT06858657Written as HSK44459